Strategy Analytics: Telecom Operators Need to Build Differentiated Competitiveness to Extend Their Business Scope
It’s time for telecom operators to set their transformation roadmap toward 2030 BOSTON–(BUSINESS WIRE)–‘Digital transformation’…
It’s time for telecom operators to set their transformation roadmap toward 2030 BOSTON–(BUSINESS WIRE)–‘Digital transformation’…
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) today announced production and…
ATLANTA & NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange (NYSE: ICE), a leading global provider of data, technology…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that details its approach to environmental, social, and governance (ESG)…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its First-Quarter 2022 U.S. Bank Compendium. The Compendium provides our latest…
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
– FTX-6058 is the only oral hemoglobin F (HbF) inducer in clinical development -Data will…
Phase 1 Multiple-Ascending Dose Data for CRN04894 Expected in 2Q22 Paltusotine’s Phase 3 PATHFNDR Trials…
◦ UCART20x22 preclinical data presented at AACR demonstrated PoC with robust in vitro and in vivo…
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or…
Initial data from pivotal FIREFLY-1 study with tovorafenib (DAY101) in relapsed pediatric low-grade glioma (pLGG)…
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a…
Positive top-line results from registration-enabling study of cosibelimab in metastatic cutaneous squamous cell carcinoma announced…
Company on track to dose first transfusion-dependent beta thalassemia patient with EDIT-301 by year-end CAMBRIDGE, Mass.,…
AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
– Peer-reviewed publication highlights 22 new oncogenic HER2 driver mutations identified and experimentally validated with…
Montrouge, France, May 12, 2022 DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary…
Internet City, Dubai–(Newsfile Corp. – May 12, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – May 12, 2022) – LBank Exchange, a global digital asset…